Oncology Market Size, Growth Opportunity 2025-2034

Oncology Market – By Cancer Diagnostics and Treatment, By Cancer Type, By End Use– Global Forecast, 2025 to 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising incidence of cancer globally

3.2.1.2&nbsp;&nbsp;&nbsp; Several initiatives undertaken by government and other organizations to spread disease awareness

3.2.1.3&nbsp;&nbsp;&nbsp; Growing number of diagnostic laboratories in developing countries

3.2.1.4&nbsp;&nbsp;&nbsp; Technological advancements in developed countries

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High capital investment coupled with high cost associated with diagnostic imaging system

3.2.2.2&nbsp;&nbsp;&nbsp; High risk of side effects associated with cancer treatment and risks associated with CT scanners

3.2.2.3&nbsp;&nbsp;&nbsp; Dearth of well-skilled and trained oncologists and radiologists

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Gap analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cancer Diagnostics and Treatment, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Cancer diagnostics

5.2.1&nbsp;&nbsp;&nbsp; Tumor biomarkers test

5.2.2&nbsp;&nbsp;&nbsp; Imaging

5.2.3&nbsp;&nbsp;&nbsp; Biopsy

5.2.4&nbsp;&nbsp;&nbsp; Liquid biopsy

5.2.5&nbsp;&nbsp;&nbsp; Immunohistochemistry

5.2.6&nbsp;&nbsp;&nbsp; In situ hybridization

5.3&nbsp;&nbsp;&nbsp; Cancer treatment

5.3.1&nbsp;&nbsp;&nbsp; Chemotherapy

5.3.2&nbsp;&nbsp;&nbsp; Targeted therapy

5.3.3&nbsp;&nbsp;&nbsp; Immunotherapy

5.3.4&nbsp;&nbsp;&nbsp; Hormonal therapy

5.3.5&nbsp;&nbsp;&nbsp; Other cancer treatments

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cancer Type, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Lung cancer

6.3&nbsp;&nbsp;&nbsp; Prostate cancer

6.4&nbsp;&nbsp;&nbsp; Colon and rectal cancer

6.5&nbsp;&nbsp;&nbsp; Gastric cancer

6.6&nbsp;&nbsp;&nbsp; Esophageal cancer

6.7&nbsp;&nbsp;&nbsp; Liver cancer

6.8&nbsp;&nbsp;&nbsp; Breast cancer

6.9&nbsp;&nbsp;&nbsp; Other cancer types

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

7.4&nbsp;&nbsp;&nbsp; Diagnostic imaging centers

7.5&nbsp;&nbsp;&nbsp; Academia

7.6&nbsp;&nbsp;&nbsp; Specialty clinics

7.7&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; Switzerland

8.3.8&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; India

8.4.3&nbsp;&nbsp;&nbsp; Japan

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Thailand

8.4.7&nbsp;&nbsp;&nbsp; Indonesia

8.4.8&nbsp;&nbsp;&nbsp; Vietnam

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Colombia

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; AbbVie

9.2&nbsp;&nbsp;&nbsp; Amgen

9.3&nbsp;&nbsp;&nbsp; AstraZeneca

9.4&nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company

9.5&nbsp;&nbsp;&nbsp; Eli Lilly and Company

9.6&nbsp;&nbsp;&nbsp; GE HealthCare Technologies

9.7&nbsp;&nbsp;&nbsp; Gilead Sciences

9.8&nbsp;&nbsp;&nbsp; GlaxoSmithKline

9.9&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson

9.10&nbsp;&nbsp;&nbsp; Merck &amp; Co

9.11&nbsp;&nbsp;&nbsp; Novartis

9.12&nbsp;&nbsp;&nbsp; Pfizer

9.13&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

9.14&nbsp;&nbsp;&nbsp; Sanofi

9.15&nbsp;&nbsp;&nbsp; Takeda Pharmaceutical Company Limited 
&nbsp;

Oncology Market

Get a free sample of this report